What is Semaglutide?
Semaglutide is a GLP-1 receptor agonist studied in metabolic, glucose, appetite, and body-weight research.
Semaglutide dosage snapshot
- Route
- subQ
- Dose range
- 0.25-2.4 mg titrated
- Frequency
- 1x weekly
- Duration
- long-term studies
Based on reported research sources; not a dosing instruction.
Potential benefits
- Weight loss
- Glucose control
- Appetite control
- Cardiometabolic health
- Long-term weight management
Safety profile
Low risk- Common: Nausea, vomiting, diarrhea, constipation, and appetite suppression.
- Less common: Injection-site reactions, fatigue, reflux, or abdominal discomfort.
- Caution: Risk varies with dose escalation, prior GLP-1 exposure, and clinical context.
Storage and handling
Store according to product-label instructions and batch handling notes. Lyophilized research peptides are commonly kept dry, protected from light, and handled with clean laboratory technique.